Preoperative Evaluation of CABG Patient Needing Non- Cardiac Surgery. Scott Davis, M.D., F.A.C.C. BHHI Primary Care Symposium February 26, 2016

Preoperative Cardiac Risk Assessment: Approach & Guidelines

Preoperative Cardiac Risk Assessment: Approach & Guidelines By, Liam Morris, MD., FACC (02/03/18) CPG : Clinical Practice Guidelines GDMT : Guidelines Directed Medical Therapy GWC : Guideline Writing Committee

Preoperative Risk. Geoffrey C Zarrella DO FACC. Assessment

Preoperative Risk Geoffrey C Zarrella DO FACC Assessment your late add ons keep calm use your tools stick to your guns PURPOSE OF THE PREOP EVAL ASSESS PERIOP RISK CAN INFORM DECISION TO PROCEED OR

Cardiac Risk Assessment in the Preoperative period

Cardiac Risk Assessment in the Preoperative period Catherine Curley, MD May, 2017 Disclosures I am not a cardiologist! 1 Case 1 78 yo man presenting to the ED after mechanical fall on his driveway. Found

Timing of Surgery After Percutaneous Coronary Intervention

Timing of Surgery After Percutaneous Coronary Intervention Deepak Talreja, MD, FACC Bayview/EVMS/Sentara Outline/Highlights Timing of elective surgery What to do with medications Stopping anti-platelet

Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease

2012 대한춘계심장학회 Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease 울산의대울산대학병원심장내과이상곤 ECG CLASS IIb 1. Preoperative resting 12-lead ECG may be reasonable in patients with

Pre-op Risk Assessment. Hal Blanks MD FACC

Pre-op Risk Assessment Hal Blanks MD FACC Objectives: Identify and manage patients with known or suspected CAD and other cardiac diseases who are at risk of cardiac complications during noncardiac surgery.

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

Cardiac evaluation for the noncardiac patient Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Objectives! Review ACC / AHA guidelines as updated for 2009! Discuss new recommendations

Agenda. Perioperative Cardiac Risk Stratification circa Surgical Mortality: What is High Risk? Presenter Disclosure Information

9:45 1:45 am Perioperative Evaluation and Management of the Cardiac Patient in Noncardiac Surgery SPEAKER Joshua A. Beckman, MD, MS Presenter Disclosure Information The following relationships exist related

Canadian Antiplatelet Therapy Guidelines: 2014 Update James D. Douketis MD, FRCP(C)

Canadian Antiplatelet Therapy Guidelines: 2014 Update James D. Douketis MD, FRCP(C) Department of Medicine, St. Joseph s Healthcare Hamilton and McMaster University, Hamilton, Canada Disclosures for: James

Asif Serajian DO FACC FSCAI

Anticoagulation and Antiplatelet update: A case based approach Asif Serajian DO FACC FSCAI No disclosures relevant to this talk Objectives 1. Discuss the indication for antiplatelet therapy for cardiac

Guidelines PATHOLOGY: FATAL PERIOPERATIVE MI NON-PMI N = 25 PMI N = 42. Prominent Dutch Cardiovascular Researcher Fired for Scientific Misconduct

PATHOLOGY: FATAL PERIOPERATIVE MI NON-PMI N = 25 PMI N = 42 Preoperative, Intraoperative, and Postoperative Factors Associated with Perioperative Cardiac Complications in Patients Undergoing Major Noncardiac

Evaluation and Management of the Patient with Cardiac Disease for Non-Cardiac Surgery WINTER CONFRENCE 2016 RONY GORGES, MD

Evaluation and Management of the Patient with Cardiac Disease for Non-Cardiac Surgery WINTER CONFRENCE 2016 RONY GORGES, MD 67 yo man Asymptomatic carotid stenosis, CEA planned Golfs regularly, walks and

Agenda. Disclosures. Surgical Mortality: What is High Risk?

Pre-Operative Cardiac Evaluation of the Vascular Patient: Updated AHA/ACC Guidelines Choosing Wisely UCSF Vascular Symposium 2015 Joshua A. Beckman, M.D., M.S. Brigham and Women s Hospital Consulting Merck

8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None

Pre-op Evaluation for non cardiac surgery John Steuter, MD Disclosures None A quick review from 2007!! Fliesheret al, ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and are for Noncardiac

SESSION 5 2:20 3:35 pm

SESSION 2:2 3:3 pm Strategies to Reduce Cardiac Risk for Noncardiac Surgery SPEAKER Lee A. Fleisher, MD Presenter Disclosure Information The following relationships exist related to this presentation:

I have no disclosures

Preparing patients for out of hospital anesthesia BobbieJean Sweitzer, M.D. Director, Anesthesia Perioperative Medicine Clinic Professor of Anesthesia and Critical Care Professor of Medicine University

Perioperative Assessment in the Older Adult. Sondra Vazirani, MD, MPH

Perioperative Assessment in the Older Adult Sondra Vazirani, MD, MPH The Preoperative Evaluation in the Older Adult Sondra Vazirani, MD, MPH, FACP* 33 rd UCLA Intensive Course in Geriatric Medicine & Pharmacy,

Perioperative Medical Therapy: Beta Blockers, Statins, ACE-Inhibitors, ARB Effects on Mortality

Perioperative Medical Therapy: Beta Blockers, Statins, ACE-Inhibitors, ARB Effects on Mortality Art Wallace, MD, PhD SF VAMC Chief of Anethesia and Vice Chair of Anesthesia and Perioperative Care UCSF

Clinical Controversies in Perioperative Medicine

Clinical Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Cardiac Evaluation: New Guidelines A 70-y.o. man with progressive

Preoperative Cardiac Evaluation:

Preoperative Cardiac Evaluation: The New Guidelines Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Disclosures No financial relationships with pharmaceutical

D M Y Y Y Y D D M M Y Y Y Y. Previous MI (apart from acute PCI) 0=no 1=yes 9=unknown

I Patient details and Preoperative Data Date of Informed Consent dd-mm-yyyy (Please leave blank if waived by Ethics Committee) Please enter Patient ID in this format xxx-xx-xxx 3 digit code for the country,

Preoperative Evaluation Guidelines and Work up

Preoperative Evaluation Guidelines and Work up Wesley Fiser, MD Disclosures: None 1 Case An 80 year old woman with osteoarthritis of the hip, DM, CKD (Cr 2.1), and HTN is diagnosed with an obstructing

Clinical Controversies in Perioperative Medicine

Update on Perioperative Medicine Clinical Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Cardiac Medications & Perioperative

Perioperative Medicine 2017 November 3, Disclosures

Perioperative Medicine 2017 November 3, 2017 Scott Marsal, MD MSc FACP Chief, Medicine Division Medical Director, Quality & Patient Safety Providence St. Vincent Medical Center Disclosures No conflicts

Perioperative Medicine 2016 Some Answers, Even More Questions

Learning Objectives Perioperative Medicine 2016 Some Answers, Even More Questions Kurt Pfeifer, MD, FACP, FHM Professor of Medicine Medical College of Wisconsin Outline changes to the ACC/AHA perioperative

Update on Perioperative Medicine. Update on Perioperative Medicine. Question 1: Clinical Risk Prediction. for the Office-based Practitioner

Update on Perioperative Medicine Update on Perioperative Medicine for the Office-based Practitioner Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Predicting

PERIOPERATIVE CARDIAC RISK ASSESSMENT. Divya Gollapudi, MD

PERIOPERATIVE CARDIAC RISK ASSESSMENT Divya Gollapudi, MD Clinical Assistant Professor Hospital Medicine Program Division of General Internal Medicine Harborview Medical Center None Disclosures Objectives

Percutaneous Coronary Intervention: Update

Percutaneous Coronary Intervention: Update Alphonse M. Ambrosia, DO, FACC Interventional Cardiologist CardioVascular Associates of Mesa Mesa, Arizona Disclosures Speakers Bureau Boston Scientific Medtronics

Update in Perioperative Medicine

Update in Perioperative Medicine Linda Venner MD FACP March 2018 Agenda 1 2 3 4 5 Optimized not Cleared Identify red flags for cardiac and pulmonary complications Optimize management Prevent delirium Don

Non ST Elevation-ACS. Michael W. Cammarata, MD

Non ST Elevation-ACS Michael W. Cammarata, MD Case Presentation 65 year old man PMH: CAD s/p stent in 2008 HTN HLD Presents with chest pressure, substernally and radiating to the left arm and jaw, similar

4/27/2015. Cardiac Events #1 cause of postoperative complications/ mortality- CHF, complete heart block, MI,

Not intended for medical clearance Identify, document, and evaluate health conditions Medication Management Stratify Risks Optimize conditions within context of surgical illness Recommend measures that

Cardiac Risk Factors and Noninvasive Cardiac Diagnosis-ECG, ECHO, et al. Martin C. Burke, DO, FACOI ACOI IM Board Review Course 2018

Cardiac Risk Factors and Noninvasive Cardiac Diagnosis-ECG, ECHO, et al. Martin C. Burke, DO, FACOI ACOI IM Board Review Course 2018 No Disclosures The American Heart Association Evidence-Based Scoring

Objectives. Old School. Preoperative Evaluation and Postoperative Complications: Where are the opportunities for risk reduction?

Preoperative Evaluation and Postoperative Complications: Where are the opportunities for risk reduction? Jeffrey Carter, MD RMHMS October 5, 2010 Objectives Understand the preoperative cardiac evaluation

Updates & Controversies in Perioperative Medicine

Updates & Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Updates in Perioperative Medicine Estimating mortality in surgical

Preoperative β-blockers before major elective vascular surgery does not improve cardiac outcomes and may be harmful

Preoperative β-blockers before major elective vascular surgery does not improve cardiac outcomes and may be harmful Salvatore Scali 1*, Virendra Patel 2*, Daniel Neal 1, Daniel Bertges 3, Karen Ho 4, Jens-Eldrup

Stress Echocardiography: Illustrative Cases Sunil Mankad, MD, FACC, FCCP, FASE Associate Professor of Medicine Mayo Clinic College of Medicine Director, Transesophageal Echocardiography Associate Director,

David A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine The Ohio State University Division of Cardiovascular Medicine Columbus, Ohio

1 STABLE ISCHEMIC HEART DISEASE: A NON-INVASIVE CARDIOLOGIST S PERSECTIVE 2018 Cardiovascular Course for Trainees and Early Career Physicians APRIL 20, 2018 David A. Orsinelli, MD, FACC, FASE Professor,

Clinical Controversies in Perioperative Medicine

Clinical Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Predicting & Managing Cardiac Risk A 70-y.o. man with progressive

Controversies in Perioperative Medicine

Controversies in Perioperative Medicine Staying Abreast & Ahead of the Guidelines Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Controversies in Perioperative

Perioperative Cardiac Management. Emma Sargsyan, MD, FACP

Perioperative Cardiac Management Emma Sargsyan, MD, FACP March 22-24, 2018 Outline Evaluation of cardiac risk prior to non-cardiac surgery Management of cardiac risk for non-cardiac surgery 2 Preop medical

by Brian Wolfe, MD Assistant Professor of Medicine, University of Colorado Denver

Perioperative Cases by Brian Wolfe, MD Assistant Professor of Medicine, University of Colorado Denver 75 yo for left knee arthroplasty Problem List Social Hx: obesity uses a walker diabetes because of

Conflicts of Interest. Evaluation of Cardiac and Pulmonary Risk in the Preop Patient. Introduction. Risk Assessment. Risk Assessment: RCRI

Evaluation of Cardiac and Pulmonary Risk in the Preop Patient Conflicts of Interest I have no conflicts of interest to declare Adam Schaffer, MD Brigham and Women s Hospital July 20, 2012 Introduction

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME

Update in Perioperative Medicine Know When to Hold Em

Update in Perioperative Medicine Know When to Hold Em Kurt Pfeifer, MD, FACP Associate Professor of Medicine Medical College of Wisconsin Learning Objectives Cardiovascular risk Risk assessment Beta-blockers

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome Chris C. Cook, MD Associate Professor of Surgery Director, CT Residency Program, WVU ACOI 10/17/18 No Disclosures

Management of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018

Management of Stable Ischemic Heart Disease Vinay Madan MD February 10, 2018 1 Disclosure No financial disclosure. 2 Overview of SIHD Diagnosis Outline of talk Functional vs. Anatomic assessment Management

SECONDARY PREVENTION WORKSHOP. May 5, 2018

SECONDARY PREVENTION WORKSHOP May 5, 2018 Disclosures Have received honourarium/speaker fees from Astra Zeneca Sanofi Objectives 1. Examine the use of beta-blockers post-mi 2. Determine the benefits and

Acute Coronary Syndromes. January 9, 2013 Chris Chiles M.D. FACC

Acute Coronary Syndromes January 9, 2013 Chris Chiles M.D. FACC Disclosures None- not even a breakfast burrito from a drug company Hospitalizations in the U.S. Due to ACS Acute Coronary Syndromes* 1.57

A preoperative evaluation allows us to: learn about the patient. risk stratify them based on their comorbities

A preoperative evaluation allows us to: learn about the patient risk stratify them based on their comorbities assists in anesthesia preop, intraop and postoperative planning COMPONENTS OF A PREOP Thorough

Cases in Stress Echo DISCLOSURE

Cases in Stress Echo Susan Wilansky, MD, FRCP(C), FACC, FASE Mayo Clinic, AZ DISCLOSURE Relevant Financial Relationship(s) None Off Label Usage None 1 Exercise Testing in Patients with HCM (Class IIa)

Hypertension in the very old. Objectives: Clinical Perspective

Harvard Medical School Hypertension in the very old Ihab Hajjar, MD, MS, AGSF Associate Director, CV Research Lab Assistant Professor of Medicine, Harvard Medical School Objectives: Describe the clinical

Revascularization for Patients with HFrEF: CABG and PCI and the Concept of Myocardial Viability

Revascularization for Patients with HFrEF: CABG and PCI and the Concept of Myocardial Viability 22nd Annual Heart Failure 2018: an Update on Therapy April 2018 Eric J. Velazquez, MD, FACP, FACC, FASE,

Clinical Controversies in Perioperative Medicine!

Clinical Controversies in Perioperative Medicine! Hugo Quinny Cheng, MD! Division of Hospital Medicine! University of California, San Francisco! Disclosures! Perioperative beta-blockade & statin therapy

Preoperative Evaluation of Patients Undergoing Noncardiac Surgery

Preoperative Evaluation of Patients Undergoing Noncardiac Surgery Shazia Khan, MD Assistant Professor of Clinical Medicine Keck School of Medicine LAC+USC Medical Center Learning Objectives Use a risk

PERIOPERATIVE ANESTHETIC RISK IN THE GERIATRIC PATIENT

PERIOPERATIVE ANESTHETIC RISK IN THE GERIATRIC PATIENT Susan H. Noorily, M.D. Clinical Professor of Anesthesiology Medical Director University Preoperative Medicine Center IMPORTANCE Half of all currently

2/20/2013. Why use imaging in CV prevention? Update on coronary CTA in 2013 Coronary CTA for 1 0 prevention: pros and cons Are we there yet?

Evolving Role of Coronary CTA in Primary Cardiovascular Disease Prevention: Are We There Yet? Ron Blankstein, M.D., F.A.C.C. Co-Director, Cardiovascular Imaging Training Program Associate Physician, Preventive

New Concepts in Acute Coronary Syndromes Beyond 2000 (XX) Interactive Case Presentations

New Concepts in Acute Coronary Syndromes Beyond 2000 (XX) Interactive Case Presentations Dr. Richard Bon Surrey Memorial Hospital, Surrey, BC Canadian Cardiovascular Congress 2014 October 26, 2014 Conflicts

PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW

PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW Bruce Biccard Perioperative Research Group, Department of Anaesthetics 18 June 2015 Disclosure Research funding received Medical Research

Cardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium. Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute

Cardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute 62 year old male Anterior STEMI late presentation, occluded

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN Objectives Gain competence in evaluating chest pain Recognize features of moderate risk unstable angina Review initial management of UA and

TRIPLE THERAPY, NOACs with concurrent indication for DAPT. Paul Wright Lead Cardiac Pharmacist The Heart, UCLH NHS Foundation Trust

TRIPLE THERAPY, NOACs with concurrent indication for DAPT Paul Wright Lead Cardiac Pharmacist The Heart, UCLH NHS Foundation Trust Content Why consider triple therapy What we know of triple therapy Current

2/17/2010. Grace Lin, MD Assistant Professor of Medicine University of California, San Francisco

Modern Management of Patients with Stable Coronary Artery Disease Grace Lin, MD Assistant Professor of Medicine University of California, San Francisco Scope of the Problem Prevalence of CAD: 17.6 million

Controversies in Cardiac Pharmacology

Controversies in Cardiac Pharmacology Thomas D. Conley, MD FACC FSCAI Disclosures I have no relevant relationships with commercial interests to disclose. 1 Doc, do I really need to take all these medicines?

Disclosures. Objectives. Cardiovascular Risk. Patient Case. JUPITER: The final frontier in statin utilization or an idea from outer space?

Disclosures JUPITER: The final frontier in statin utilization or an idea from outer space? Kathy E. Komperda, PharmD, BCPS Midwestern University Chicago College of Pharmacy kkompe@midwestern.edu 4/25/09

An algorithmic approach to the very high risk surgical patient

An algorithmic approach to the very high risk surgical patient Daniel A. Reuter Center of Anesthesiology and Intensive Care Medicine Hamburg-Eppendorf Universiy Medical Center Disclosures: Member of the

Beta-blockers: Now what? Annemarie Thompson, MD Assistant Professor of Anesthesia and Medicine Vanderbilt University Medical Center

Beta-blockers: Now what? Annemarie Thompson, MD Assistant Professor of Anesthesia and Medicine Vanderbilt University Medical Center Beta-blockers: What s known 30 Years 30 Careers Physician clarity regarding

Case Presentation #1

Case Presentation #1 SCAI Fellows Course December 7, 2013 Barry F Uretsky, MD University of Arkansas for Medical Sciences Central Arkansas Veterans Health System Little Rock, AR Case Presentation #1 65

Value of troponin measurements in carotid artery revascularization

Value of troponin measurements in carotid artery revascularization Gert J de Borst Department of Vascular Surgery Postoperative myocardial infarction after NCS: Magnitude of the problem POISE-1: 367 /8,351=

Surveying the Landscape of Oral Antiplatelet Therapy in Acute Coronary Syndrome Management

Surveying the Landscape of Oral Antiplatelet Therapy in Acute Coronary Syndrome Management Jeffrey S Berger, MD, MS Assistant Professor of Medicine and Surgery Director of Cardiovascular Thrombosis Disclosures

Disclosures. Inpatient Management of Non-ST Elevation Acute Coronary Syndromes. Edward McNulty MD, FACC. None

Inpatient Management of Non-ST Elevation Acute Coronary Syndromes Edward McNulty MD, FACC Assistant Clinical Professor UCSF Director, SF VAMC Cardiac Catheterization Laboratory Disclosures None New Guidelines

Optimal Duration and Dose of Antiplatelet Therapy after PCI

Optimal Duration and Dose of Antiplatelet Therapy after PCI Donghoon Choi, MD, PhD Severance Cardiovascular Center Yonsei University College of Medicine Optimal Duration of Antiplatelet Therapy after PCI

UPDATES FROM THE 2018 ANTIPLATELET GUIDELINES

UPDATES FROM THE 2018 ANTIPLATELET GUIDELINES Claudia Bucci BScPhm, PharmD Clinical Coordinator, Cardiovascular Diseases Sunnybrook Health Sciences Centre 21st Annual Contemporary Therapeutic Issues in

2/26/2013. NCDR.13 Case Scenario Presentation Cath PCI Registry. Disclosures. Objectives. Dashboard Implications of Some Major Metrics

NCDR.13 Case Scenario Presentation Cath PCI Registry Dashboard Implications of Some Major Metrics Disclosures Tony Hermann has nothing to disclose Mark Hutcheson has nothing to disclose Cornelia Anderson

Dual Antiplatelet Therapy Made Practical

Dual Antiplatelet Therapy Made Practical David Parra, Pharm.D., FCCP, BCPS Clinical Pharmacy Program Manager in Cardiology/Anticoagulation VISN 8 Pharmacy Benefits Management Clinical Associate Professor

Perioperative Risk Assessment Do patients really need to be cleared for the OR?

Perioperative Risk Assessment Do patients really need to be cleared for the OR? Dr. Eric Lindley McKay-Dee Cardiology Adjunct Assistant Professor University of Utah Disclosures Consultant: Abbott vascular

What s New in Antiplatelet Therapy and DES in 2016

What s New in Antiplatelet Therapy and DES in 2016 Peter Pollak MD Director of Structural Heart Disease & Intervention Mayo Clinic Florida 2016 slide-1 Disclosures Financial None Off-label - None 2016

CCS Perioperative Guidelines When to order a BNP and What to do with a Positive Troponin

Canadian Society of Internal Medicine Annual Meeting 2017 Toronto, ON CCS Perioperative Guidelines When to order a BNP and What to do with a Positive Troponin Dr. Vikas Tandon Associate Professor, Cardiology

March yr. old male, newspaper writer, with worsening dyspnea /orthopnea past few months

Case 1 March 2016 59 yr. old male, newspaper writer, with worsening dyspnea /orthopnea past few months PMH diabetes, celiac disease Reports chest discomfort, positional coughing and pedal edema last 10

Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής. Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά

Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά International ACS guidelines: Recommendations on duration of dual

Pre-Operative Services Teaching Rounds 3 Jan 2011

Pre-Operative Services Teaching Rounds 3 Jan 2011 Deborah Richman MBChB FFA(SA) Director Pre-Operative Services Department of Anesthesia Stony Brook University Medical Center, NY drichman@notes.cc.sunysb.edu

Managing the Low Output Low Gradient Aortic Stenosis Patient

Managing the Low Output Low Gradient Aortic Stenosis Patient R A Nishimura MD Judd and Mary Leighton Professor of CV Mayo Clinic No disclosures Valvular Stenosis Severity of Aortic Stenosis Mean gradient

Efficacy and Safety of a Dual Ticagrelor plus Aspirin Antiplatelet Strategy after Coronary Artery Bypass Grafting: The DACAB Randomized Clinical Trial

Efficacy and Safety of a Dual Ticagrelor plus Aspirin Antiplatelet Strategy after Coronary Artery Bypass Grafting: The DACAB Randomized Clinical Trial Qiang Zhao 1 Yunpeng Zhu 1, Zhiyun u 2, Zhaoyun Cheng

Overcoming the Risk-Treatment Paradox in Non-STE ACS: It s Time! Christopher Granger, MD

Overcoming the Risk-Treatment Paradox in Non-STE ACS: It s Time! Christopher Granger, MD Disclosures Research contracts: AstraZeneca, Bayer, Novartis, GSK, Sanofi-Aventis, BMS, Pfizer, The Medicines Company,

Benefit of Performing PCI Based on FFR

Benefit of Performing PCI Based on FFR William F. Fearon, MD Associate Professor Director, Interventional Cardiology Stanford University Medical Center Benefit of FFR-Guided PCI FFR-Guided PCI vs. Angiography-Guided

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class

James M. Kirshenbaum, MD, FACC

James M. Kirshenbaum, MD, FACC Associate Professor of Medicine Harvard Medical School Co-Director, Clinical Cardiology Director, Acute Interventional Cardiology Brigham and Women s Hospital Boston, MA

Evaluating the Heart before Non-Cardiac Surgery

Evaluating the Heart before Non-Cardiac Surgery Dr Rob Stephens Anaesthetist UCLH + UCL the centre for Anaesthesia www.ucl.ac.uk/anaesthesia/people/stephens Google UCL Stephens www.ucl.ac.uk/anaesthesia/people/stephens

Beta Blockade. Andre P. Marshall, PGY2 8/14/09 VANDERBILT SURGERY

Beta Blockade Andre P. Marshall, PGY2 8/14/09 Beta Blockade Who are the Betas anyway? When, why, and how do we block them? The Beta Receptor B 1 : cardiac chronotropic and inotropic B 2 : bronchodilation,

Pre-operative Evaluations. Objectives. General Considerations. FP Consultation Considerations. CV Credits 7/24/2017. Brian Bachelder, MD Akron, Ohio

Pre-operative Evaluations Brian Bachelder, MD Akron, Ohio Objectives Discuss the perioperative cardiopulmonary evaluation and management of patients undergoing non-cardiac surgery Objectively estimate

J. Schwitter, MD, FESC Section of Cardiology

J. Schwitter, MD, FESC Section of Cardiology CMR Center of the CHUV University Hospital Lausanne - CHUV Switzerland Centre de RM Cardiaque J. Schwitter, MD, FESC Section of Cardiology CMR Center of the

Stable Ischemic Heart Disease

Stable Ischemic Heart Disease 2016 Jane A. Linderbaum MS, CNP, AACC Mayo Medical Center Rochester, MN Assistant Professor of Medicine Associate Medical Editor AskMayoExpert linderbaum.jane@mayo.edu NO

Anesthesia for Cardiac Patients for Non Cardiac Surgery. Kimberly Westra DNP, MSN, CRNA

Anesthesia for Cardiac Patients for Non Cardiac Surgery Kimberly Westra DNP, MSN, CRNA Anesthesia for Cardiac Patients for Non Cardiac Surgery Heart Disease is a significant problem in the United States:

Belinda Green, Cardiologist, SDHB, 2016

Acute Coronary syndromes All STEMI ALL Non STEMI Unstable angina Belinda Green, Cardiologist, SDHB, 2016 Thrombus in proximal LAD Underlying pathophysiology Be very afraid for your patient Wellens

Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial

compared with clopidogrel in patients with acute coronary syndromes the PLATO trial August 30, 2009 at 08.00 CET PLATO background In NSTE-ACS and STEMI, current guidelines recommend 12 months aspirin and

Learning Objectives. Epidemiology of Acute Coronary Syndrome

Cardiovascular Update: Antiplatelet therapy in acute coronary syndromes PHILLIP WEEKS, PHARM.D., BCPS-AQ CARDIOLOGY Learning Objectives Interpret guidelines as they relate to constructing an antiplatelet

Pre-operative Assessment. Dr Will Dooley

Pre-operative Assessment Dr Will Dooley Plan Assessment structure Investigation options Exam format Why is it important?? Reduce morbidity and mortality Risk management Keep surgeon/anaesthetist happy

TAVR 2018: Cost-effective according to baseline patient risk. A real-world case example

TAVR 2018: Cost-effective according to baseline patient risk A real-world case example Male, 74 years old HTN, dyslipidaemia, CAD, PAD Past Hx 1991: CABG (LIMA LAD, SVG RCA) 2014: carotid endarterectomy

Assessing Myocardium at Risk: Applying SYNTAX

Assessing Myocardium at Risk: Applying SYNTAX Farouc Jaffer MD PhD FSCAI FACC FAHA Associate Professor of Medicine, Harvard Medical School Director, CAD Program and Chronic Total Occlusion PCI Program

Scope of the Problem: DAPT and Triple Therapy after Stenting

Scope of the Problem: DAPT and Triple Therapy after Stenting Kurt Huber, MD, FESC, FACC 3 rd Medical Department Cardiology & Emergency Medicine Wilhelminenhospital Vienna, Austria Session, August 30, 2010,

Chronic Total Occlusion: A case for coronary artery bypass grafting

Chronic Total Occlusion: A case for coronary artery bypass grafting Prof. Alfredo R Galassi MD, FESC, FACC, FSCAI Director of Cardiac Catheterization and Interventional Cardiology Unit Department of Medical